From 20 years on the vendor side and now on the program side, the math that wins capital approval is not the math the program runs in year two. The reimbursement environment moved more than the headline rate change. <a rel="noopener noreferrer nofollow" href="http://medsolvedynamics.com" target="_blank">medsolvedynamics.com</a> | <a rel="noopener noreferrer nofollow" href="mailto:team@medsolvedynamics.com" target="_blank">team@medsolvedynamics.com</a>

From 20 years on the vendor side and now on the program side, the math that wins capital approval is not the math the program runs in year two. The reimbursement environment moved more than the headline rate change. medsolvedynamics.com | team@medsolvedynamics.com

From 20 years on the vendor side and now on the program side, the math that wins capital approval is not the math the program runs in year two. The reimbursement environment moved more than the headline rate change. <a href="http://medsolvedynamics.com" rel="noopener noreferrer">medsolvedynamics.com</a> | <a href="mailto:team@medsolvedynamics.com" rel="noopener noreferrer">team@medsolvedynamics.com</a>

The Proforma Altitude Problem In 2026 Oncology Capital Decisions

Short, operator-level strategy for radiation oncology and cancer program leaders navigating margin pressure, capital decisions, and AI reality. No fluff. No pitch. Just what the vendor isn't telling you.

Business

Medicine

Health & Fitness

Short, operator-level strategy for radiation oncology and cancer program leaders navigating margin pressure, capital decisions, and AI reality. No fluff. No pitch. Just what the vendor isn't telling you.

Share The Proforma Altitude Problem In 2026 Oncology Capital Decisions

Sign up to save your podcasts

The Proforma Altitude Problem In 2026 Oncology Capital Decisions

The Proforma Altitude Problem In 2026 Oncology Capital Decisions